Spyre Therapeutics: Pay

Spyre Therapeutics paid its 4 named executives $13.3M in total in FY2025 (Dec). CEO Cameron Turtle was paid $6.7M of that.

Pay$100 in the stock at the end of FY22 → $291
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Cameron TurtleChief Executive Officer
FY2025 (Dec)
FY2024 (Dec)Not disclosed
FY2023 (Dec)Not disclosed
3 years
Sheldon SloanChief Medical Officer
FY2025 (Dec)
FY2024 (Dec)Not disclosed
2 years
Heidy King-JonesChief Legal Officer and Corporate Secretary
FY2025 (Dec)
FY2024 (Dec)Not disclosed
FY2023 (Dec)Not disclosed
3 years
Scott BurrowsChief Financial Officer
FY2025 (Dec)
FY2024 (Dec)Not disclosed
FY2023 (Dec)Not disclosed
3 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 6 peers with pay on file was $7.7M. The CEO of Spyre Therapeutics was paid $6.7M, 13% below the median.

  1. 1Disc Medicine
  2. 2Kymera Therapeutics
  3. 3Structure Therapeutics
  4. 4Vera Therapeutics
  5. 5Spyre Therapeutics
  6. 6Nurix Therapeutics
  7. 7Celldex Therapeutics
  8. 8AnaptysBio, Inc.Not disclosed
  9. 9Apogee Therapeutics, Inc.Not disclosed
  10. 10Arcellx, Inc.Not disclosed
  11. 11Astria Therapeutics, Inc.Not disclosed
  12. 12Contineum Therapeutics, Inc.Not disclosed
  13. 13Dyne TherapeuticsNot disclosed
  14. 14IGM Biosciences, Inc.Not disclosed
  15. 15Janux TherapeuticsNot disclosed
  16. 16Keros Therapeutics, Inc.Not disclosed
  17. 17Pliant Therapeutics, Inc.Not disclosed
  18. 18Stoke Therapeutics, Inc.Not disclosed
  19. 19Xencor Inc.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.